Citigroup’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.7K | Sell |
8,594
-1,500
| -15% | -$16.7K | ﹤0.01% | 3697 |
|
|
2025
Q1 | $124K | Sell |
10,094
-1,013
| -9% | -$12.5K | ﹤0.01% | 3714 |
|
|
2024
Q4 | $124K | Buy |
11,107
+1,263
| +13% | +$14.1K | ﹤0.01% | 3883 |
|
|
2024
Q3 | $68.6K | Buy |
9,844
+6,875
| +232% | +$47.9K | ﹤0.01% | 4140 |
|
|
2024
Q2 | $22.4K | Sell |
2,969
-72,719
| -96% | -$550K | ﹤0.01% | 4234 |
|
|
2024
Q1 | $999K | Buy |
75,688
+40,667
| +116% | +$537K | ﹤0.01% | 2364 |
|
|
2023
Q4 | $361K | Buy |
35,021
+32,037
| +1,074% | +$330K | ﹤0.01% | 2892 |
|
|
2023
Q3 | $29K | Buy |
+2,984
| New | +$29K | ﹤0.01% | 3600 |
|
|
2022
Q3 | – | Sell |
-62
| Closed | – | – | 5269 |
|
|
2022
Q2 | $0 | Sell |
62
-194
| -76% | – | ﹤0.01% | 5615 |
|
|
2022
Q1 | $2K | Sell |
256
-1,583
| -86% | -$12.4K | ﹤0.01% | 5251 |
|
|
2021
Q4 | $19K | Buy |
1,839
+1,021
| +125% | +$10.5K | ﹤0.01% | 4628 |
|
|
2021
Q3 | $13K | Buy |
818
+487
| +147% | +$7.74K | ﹤0.01% | 4645 |
|
|
2021
Q2 | $8K | Buy |
+331
| New | +$8K | ﹤0.01% | 5062 |
|